• FirefoxInstall the new Firefox »
  •  Dow Up 0.69% Nasdaq Up 0.73%

    Alexza Pharmaceuticals Inc. (ALXA)

    -NasdaqGM
    2.06 Down 0.05(2.37%) 3:23PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:2.11
    Open:2.13
    Bid:2.07 x 4900
    Ask:2.09 x 100
    1y Target Est:8.50
    Beta:0.46
    Next Earnings Date: 9-Mar-15ALXA Earnings announcement
    Day's Range:2.06 - 2.19
    52wk Range:1.25 - 5.68
    Volume:31,356
    Avg Vol (3m):128,072
    Market Cap:39.97M
    P/E (ttm):N/A
    EPS (ttm):-2.06
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ALXA

    Comparison

    Symbol% ChgMkt Cap
    ALXADown 2.37%39.97M
    ALKSUp 1.62%10.57B
    ARDMDown 0.48%108.99M
    LLYUp 1.19%75.31B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):7.56
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-2.35
    Quarterly EPS Est (Dec-14) :-0.68
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alexza Pharmaceuticals, Inc., a pharmaceutical company, focuses on the research, development, and commercialization of novel proprietary products for the acute treatment of central nervous system conditions worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback